233 related articles for article (PubMed ID: 23635555)
21. Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls.
Zhang L; Long X
Sci Rep; 2015 Aug; 5():12773. PubMed ID: 26239137
[TBL] [Abstract][Full Text] [Related]
22. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC
Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.
Orr N; Cooke R; Jones M; Fletcher O; Dudbridge F; Chilcott-Burns S; Tomczyk K; Broderick P; Houlston R; Ashworth A; Swerdlow A
PLoS Genet; 2011 Sep; 7(9):e1002290. PubMed ID: 21949660
[TBL] [Abstract][Full Text] [Related]
24. Previous GWAS hits in relation to young-onset breast cancer.
Shi M; O'Brien KM; Sandler DP; Taylor JA; Zaykin DV; Weinberg CR
Breast Cancer Res Treat; 2017 Jan; 161(2):333-344. PubMed ID: 27848153
[TBL] [Abstract][Full Text] [Related]
25. Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm.
Sapkota Y; Yasui Y; Lai R; Sridharan M; Robson PJ; Cass CE; Mackey JR; Damaraju S
PLoS One; 2013; 8(5):e62550. PubMed ID: 23717390
[TBL] [Abstract][Full Text] [Related]
26. Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.
He X; Yao G; Li F; Li M; Yang X
Int J Mol Sci; 2014 Jan; 15(2):2130-41. PubMed ID: 24481062
[TBL] [Abstract][Full Text] [Related]
27. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
Liang J; Chen P; Hu Z; Shen H; Wang F; Chen L; Li M; Tang J; Wang H; Shen H
Breast Cancer Res Treat; 2010 Nov; 124(1):237-41. PubMed ID: 20213080
[TBL] [Abstract][Full Text] [Related]
29. The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk.
Warren Andersen S; Trentham-Dietz A; Gangnon RE; Hampton JM; Figueroa JD; Skinner HG; Engelman CD; Klein BE; Titus LJ; Newcomb PA
Breast Cancer Res Treat; 2013 Jul; 140(2):427-34. PubMed ID: 23893088
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer susceptibility loci and influence on survival.
Song N; Kim K; Shin A; Park JW; Chang HJ; Shi J; Cai Q; Kim DY; Zheng W; Oh JH
Genes Chromosomes Cancer; 2018 Dec; 57(12):630-637. PubMed ID: 30350386
[TBL] [Abstract][Full Text] [Related]
31. Evaluating genome-wide association study-identified breast cancer risk variants in African-American women.
Long J; Zhang B; Signorello LB; Cai Q; Deming-Halverson S; Shrubsole MJ; Sanderson M; Dennis J; Michailidou K; Easton DF; Shu XO; Blot WJ; Zheng W
PLoS One; 2013; 8(4):e58350. PubMed ID: 23593120
[TBL] [Abstract][Full Text] [Related]
32. Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort.
Woolcott CG; Maskarinec G; Haiman CA; Verheus M; Pagano IS; Le Marchand L; Henderson BE; Kolonel LN
Breast Cancer Res; 2009; 11(1):R10. PubMed ID: 19232126
[TBL] [Abstract][Full Text] [Related]
33. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
[TBL] [Abstract][Full Text] [Related]
34. Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.
Tajbakhsh A; Javan FA; Rivandi M; Moezzi A; Abedini S; Asghari M; Farjami Z; Soltanian H; Shandiz FH; Kooshyar MM; Pasdar A
Mol Biol Rep; 2019 Feb; 46(1):805-811. PubMed ID: 30515698
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
36. Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects.
Chen MB; Wu XY; Shen W; Wei MX; Li C; Cai B; Tao GQ; Lu PH
Breast Cancer Res Treat; 2011 Feb; 126(1):177-83. PubMed ID: 20703937
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients.
Rath M; Li Q; Li H; Lindström S; Miron A; Miron P; Dowton AE; Meyer ME; Larson BG; Pomerantz M; Seo JH; Collins LC; Vardeh H; Brachtel E; Come SE; Borges V; Schapira L; Tamimi RM; Partridge AH; Freedman M; Ruddy KJ
PLoS One; 2019; 14(5):e0216997. PubMed ID: 31125336
[TBL] [Abstract][Full Text] [Related]
38. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.
Zheng Y; Ogundiran TO; Falusi AG; Nathanson KL; John EM; Hennis AJ; Ambs S; Domchek SM; Rebbeck TR; Simon MS; Nemesure B; Wu SY; Leske MC; Odetunde A; Niu Q; Zhang J; Afolabi C; Gamazon ER; Cox NJ; Olopade CO; Olopade OI; Huo D
Carcinogenesis; 2013 Jul; 34(7):1520-8. PubMed ID: 23475944
[TBL] [Abstract][Full Text] [Related]
39. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study.
Kim HC; Lee JY; Sung H; Choi JY; Park SK; Lee KM; Kim YJ; Go MJ; Li L; Cho YS; Park M; Kim DJ; Oh JH; Kim JW; Jeon JP; Jeon SY; Min H; Kim HM; Park J; Yoo KY; Noh DY; Ahn SH; Lee MH; Kim SW; Lee JW; Park BW; Park WY; Kim EH; Kim MK; Han W; Lee SA; Matsuo K; Shen CY; Wu PE; Hsiung CN; Lee JY; Kim HL; Han BG; Kang D
Breast Cancer Res; 2012 Mar; 14(2):R56. PubMed ID: 22452962
[TBL] [Abstract][Full Text] [Related]
40. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
